Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.

Source:http://linkedlifedata.com/resource/pubmed/id/9028550

Download in:

View as

General Info

PMID
9028550